Small cap, similar pricing to VRNG, recent patent approvals with more pending, and FDA approval for their laser technology to expand in to medical treatments. Conference call on March 6th for BIOL should offer some direction from here.
Or, if you want to go short, pick up a deep in the money put on NFLX, over momentum ran it up way past any reasonable valuation, Fed's exiting of QE would kill any momentum stocks, not to mention classifiying expenses as assets to be drepreciated over time, instead of when they were incurred, thereby making it look like they made more money than they did. I see a correction in to the 130's coming soon with a brief overlay at the 50 dma.
Take your pick of glass half full, or half empty :)